| 0 |
LEUKAEMIC INFILTRATION EXTRAMEDULLARY |
193 |
0.7569 |
| 1 |
LINEAGE SWITCH LEUKAEMIA |
35 |
0.6604 |
| 2 |
ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY |
84 |
0.6222 |
| 3 |
PRECURSOR B-LYMPHOBLASTIC LYMPHOMA RECURRENT |
15 |
0.5357 |
| 4 |
CENTRAL NERVOUS SYSTEM LEUKAEMIA |
204 |
0.5191 |
| 5 |
LEUKAEMIC INFILTRATION RENAL |
11 |
0.4583 |
| 6 |
B PRECURSOR TYPE ACUTE LEUKAEMIA |
172 |
0.4433 |
| 7 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
1121 |
0.4340 |
| 8 |
BONE MARROW LEUKAEMIC CELL INFILTRATION |
31 |
0.3780 |
| 9 |
CD19 ANTIGEN LOSS |
5 |
0.3125 |
| 10 |
MINIMAL RESIDUAL DISEASE |
102 |
0.2112 |
| 11 |
B-CELL TYPE ACUTE LEUKAEMIA |
139 |
0.1894 |
| 12 |
GERM CELL NEOPLASM |
4 |
0.1818 |
| 13 |
CSF LYMPHOCYTE COUNT INCREASED |
11 |
0.1774 |
| 14 |
COSTAL CARTILAGE FRACTURE |
6 |
0.1765 |
| 15 |
ACUTE BIPHENOTYPIC LEUKAEMIA |
16 |
0.1720 |
| 16 |
B-CELL APLASIA |
32 |
0.1240 |
| 17 |
ASPIRATION BONE MARROW ABNORMAL |
16 |
0.1185 |
| 18 |
BLAST CELL COUNT INCREASED |
122 |
0.1164 |
| 19 |
CSF CELL COUNT INCREASED |
17 |
0.1149 |
| 20 |
LEUKAEMIA CUTIS |
15 |
0.0974 |
| 21 |
TRANSPLANTATION COMPLICATION |
39 |
0.0929 |
| 22 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
251 |
0.0886 |
| 23 |
TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA |
55 |
0.0838 |
| 24 |
METASTASES TO RETROPERITONEUM |
12 |
0.0706 |
| 25 |
BLAST CELL COUNT DECREASED |
5 |
0.0685 |
| 26 |
METASTASES TO MUSCLE |
12 |
0.0663 |
| 27 |
VASCULAR ACCESS SITE OCCLUSION |
5 |
0.0633 |
| 28 |
HAEMATOPOIETIC STEM CELL MOBILISATION |
4 |
0.0625 |
| 29 |
HAEMOLYTIC TRANSFUSION REACTION |
4 |
0.0615 |
| 30 |
BLAST CELLS PRESENT |
28 |
0.0582 |
| 31 |
CYTOKINE RELEASE SYNDROME |
1150 |
0.0573 |
| 32 |
PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION |
7 |
0.0560 |
| 33 |
ACHROMOBACTER INFECTION |
6 |
0.0500 |
| 34 |
PHILADELPHIA POSITIVE ACUTE LYMPHOCYTIC LEUKAEMIA |
8 |
0.0491 |
| 35 |
METAMYELOCYTE COUNT INCREASED |
7 |
0.0470 |
| 36 |
SPONTANEOUS BACTERIAL PERITONITIS |
11 |
0.0451 |
| 37 |
CHRONIC GRAFT VERSUS HOST DISEASE IN EYE |
9 |
0.0443 |
| 38 |
POST-DEPLETION B-CELL RECOVERY |
5 |
0.0439 |
| 39 |
LEUKAEMIC INFILTRATION |
6 |
0.0429 |
| 40 |
HEPATIC CALCIFICATION |
7 |
0.0424 |
| 41 |
VASCULAR DEVICE OCCLUSION |
14 |
0.0413 |
| 42 |
SECONDARY HYPERTHYROIDISM |
4 |
0.0412 |
| 43 |
PHILADELPHIA CHROMOSOME POSITIVE |
30 |
0.0410 |
| 44 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
242 |
0.0408 |
| 45 |
ACUTE MOTOR-SENSORY AXONAL NEUROPATHY |
9 |
0.0391 |
| 46 |
GRAFT VERSUS HOST DISEASE IN EYE |
9 |
0.0390 |
| 47 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
11 |
0.0387 |
| 48 |
CD19 LYMPHOCYTES DECREASED |
5 |
0.0385 |
| 49 |
MYELOCYTE COUNT INCREASED |
7 |
0.0372 |
| 50 |
CRYPTOCOCCAL FUNGAEMIA |
5 |
0.0350 |
| 51 |
GRAFT VERSUS HOST DISEASE IN SKIN |
76 |
0.0345 |
| 52 |
BONE MARROW NECROSIS |
8 |
0.0342 |
| 53 |
ADRENOMEGALY |
7 |
0.0337 |
| 54 |
ADENOVIRAL HAEMORRHAGIC CYSTITIS |
7 |
0.0337 |
| 55 |
NEUROTOXICITY |
584 |
0.0333 |
| 56 |
CHLOROMA |
14 |
0.0332 |
| 57 |
CHRONIC GRAFT VERSUS HOST DISEASE ORAL |
8 |
0.0327 |
| 58 |
GRAFT VERSUS HOST DISEASE IN LIVER |
23 |
0.0321 |
| 59 |
FUSARIUM INFECTION |
22 |
0.0314 |
| 60 |
TRICHOSPORON INFECTION |
12 |
0.0296 |
| 61 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
62 |
0.0291 |
| 62 |
METASTASES TO SPLEEN |
12 |
0.0291 |
| 63 |
DEVICE RELATED BACTERAEMIA |
9 |
0.0290 |
| 64 |
RETROPERITONEAL MASS |
4 |
0.0290 |
| 65 |
LEUKAEMIA RECURRENT |
49 |
0.0290 |
| 66 |
VENOOCCLUSIVE DISEASE |
71 |
0.0283 |
| 67 |
SUBDURAL HYGROMA |
8 |
0.0263 |
| 68 |
METASTASES TO BONE MARROW |
13 |
0.0260 |
| 69 |
ASPERGILLUS TEST POSITIVE |
8 |
0.0260 |
| 70 |
ACUTE GRAFT VERSUS HOST DISEASE |
119 |
0.0260 |
| 71 |
ALLOGENIC STEM CELL TRANSPLANTATION |
4 |
0.0253 |
| 72 |
VENOOCCLUSIVE LIVER DISEASE |
119 |
0.0241 |
| 73 |
ACUTE MYELOMONOCYTIC LEUKAEMIA |
6 |
0.0238 |
| 74 |
FIBRIN DEGRADATION PRODUCTS INCREASED |
7 |
0.0236 |
| 75 |
INTERLEUKIN LEVEL INCREASED |
13 |
0.0236 |
| 76 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
64 |
0.0231 |
| 77 |
GRAFT VERSUS HOST DISEASE IN LUNG |
11 |
0.0230 |
| 78 |
CHRONIC GRAFT VERSUS HOST DISEASE |
81 |
0.0224 |
| 79 |
INFUSION SITE HAEMORRHAGE |
73 |
0.0222 |
| 80 |
ACUTE MONOCYTIC LEUKAEMIA |
4 |
0.0220 |
| 81 |
BLOOD LACTATE DEHYDROGENASE DECREASED |
7 |
0.0210 |
| 82 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
19 |
0.0205 |
| 83 |
MONOCYTOSIS |
12 |
0.0193 |
| 84 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
7 |
0.0192 |
| 85 |
REFRACTORY CANCER |
4 |
0.0187 |
| 86 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
26 |
0.0184 |
| 87 |
TRACHEITIS |
14 |
0.0184 |
| 88 |
DEVICE RELATED THROMBOSIS |
18 |
0.0183 |
| 89 |
CATHETER SITE THROMBOSIS |
5 |
0.0182 |
| 90 |
SYSTEMIC MYCOSIS |
21 |
0.0180 |
| 91 |
DISSEMINATED MUCORMYCOSIS |
7 |
0.0178 |
| 92 |
TRANSPLANT EVALUATION |
9 |
0.0177 |
| 93 |
ENGRAFTMENT SYNDROME |
10 |
0.0169 |
| 94 |
CHRONIC MYELOID LEUKAEMIA RECURRENT |
9 |
0.0165 |
| 95 |
DEVICE PROGRAMMING ERROR |
5 |
0.0158 |
| 96 |
LYMPHOCYTIC LEUKAEMIA |
6 |
0.0147 |
| 97 |
KLEBSIELLA BACTERAEMIA |
14 |
0.0147 |
| 98 |
GRAFT VERSUS HOST DISEASE |
106 |
0.0147 |
| 99 |
INTENTION TREMOR |
8 |
0.0141 |
| 100 |
MYELOID LEUKAEMIA |
7 |
0.0140 |
| 101 |
ESCHERICHIA BACTERAEMIA |
31 |
0.0132 |
| 102 |
DECREASED EYE CONTACT |
4 |
0.0132 |
| 103 |
CYTOKINE STORM |
9 |
0.0131 |
| 104 |
ERYTHROPOIESIS ABNORMAL |
4 |
0.0131 |
| 105 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
5 |
0.0129 |
| 106 |
APRAXIA |
19 |
0.0128 |
| 107 |
GENE MUTATION |
25 |
0.0126 |
| 108 |
AGNOSIA |
3 |
0.0126 |
| 109 |
PARAKERATOSIS |
4 |
0.0123 |
| 110 |
TUMOUR ASSOCIATED FEVER |
5 |
0.0122 |
| 111 |
FUNGAEMIA |
19 |
0.0121 |
| 112 |
MUSCLE STRENGTH ABNORMAL |
5 |
0.0119 |
| 113 |
DISSEMINATED CRYPTOCOCCOSIS |
9 |
0.0119 |
| 114 |
COMPLICATIONS OF TRANSPLANT SURGERY |
6 |
0.0119 |
| 115 |
HYPOGAMMAGLOBULINAEMIA |
78 |
0.0119 |
| 116 |
CAPILLARY LEAK SYNDROME |
24 |
0.0116 |
| 117 |
DYSMETRIA |
7 |
0.0116 |
| 118 |
JAW OPERATION |
10 |
0.0112 |
| 119 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
8 |
0.0111 |
| 120 |
COMPLICATIONS OF BONE MARROW TRANSPLANT |
4 |
0.0111 |
| 121 |
CATHETER SITE RASH |
5 |
0.0111 |
| 122 |
HYPERPHOSPHATAEMIA |
23 |
0.0107 |
| 123 |
NEOPLASM RECURRENCE |
36 |
0.0106 |
| 124 |
LEUKOENCEPHALOPATHY |
39 |
0.0105 |
| 125 |
CYSTITIS VIRAL |
4 |
0.0104 |
| 126 |
TUMOUR LYSIS SYNDROME |
90 |
0.0102 |
| 127 |
BLOOD FIBRINOGEN INCREASED |
8 |
0.0101 |
| 128 |
ARACHNOIDITIS |
7 |
0.0101 |
| 129 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
65 |
0.0101 |
| 130 |
INCORRECT DRUG ADMINISTRATION RATE |
43 |
0.0101 |
| 131 |
NEUROLOGICAL SYMPTOM |
57 |
0.0100 |
| 132 |
CSF TEST ABNORMAL |
5 |
0.0099 |
| 133 |
BLOOD FIBRINOGEN DECREASED |
11 |
0.0096 |
| 134 |
POSTURING |
5 |
0.0096 |
| 135 |
HEPATOBILIARY DISEASE |
6 |
0.0096 |
| 136 |
B-LYMPHOCYTE COUNT DECREASED |
13 |
0.0095 |
| 137 |
BLOOD PRODUCT TRANSFUSION DEPENDENT |
4 |
0.0095 |
| 138 |
PROCALCITONIN INCREASED |
11 |
0.0094 |
| 139 |
HYPERFERRITINAEMIA |
4 |
0.0093 |
| 140 |
DIAPHRAGMATIC DISORDER |
7 |
0.0092 |
| 141 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
12 |
0.0091 |
| 142 |
INTERCEPTED PRODUCT PREPARATION ERROR |
111 |
0.0090 |
| 143 |
METAPNEUMOVIRUS INFECTION |
7 |
0.0089 |
| 144 |
CYTOPENIA |
109 |
0.0089 |
| 145 |
IMMUNOGLOBULINS DECREASED |
12 |
0.0087 |
| 146 |
IIIRD NERVE PARALYSIS |
7 |
0.0087 |
| 147 |
TRANSPLANT FAILURE |
21 |
0.0086 |
| 148 |
DEVICE INFUSION ISSUE |
21 |
0.0085 |
| 149 |
MYOCARDIAL INJURY |
9 |
0.0080 |
| 150 |
ADENOVIRUS INFECTION |
23 |
0.0079 |
| 151 |
HYPERLEUKOCYTOSIS |
7 |
0.0079 |
| 152 |
PNEUMONIA FUNGAL |
31 |
0.0079 |
| 153 |
CYTOMEGALOVIRUS TEST POSITIVE |
14 |
0.0078 |
| 154 |
PARVOVIRUS B19 INFECTION |
7 |
0.0078 |
| 155 |
SLOW RESPONSE TO STIMULI |
10 |
0.0077 |
| 156 |
BK VIRUS INFECTION |
26 |
0.0077 |
| 157 |
FEBRILE INFECTION |
9 |
0.0076 |
| 158 |
ENTEROCOLITIS INFECTIOUS |
7 |
0.0076 |
| 159 |
ENTEROCOCCAL BACTERAEMIA |
8 |
0.0075 |
| 160 |
SUPERIOR SAGITTAL SINUS THROMBOSIS |
6 |
0.0075 |
| 161 |
HAPTOGLOBIN DECREASED |
6 |
0.0074 |
| 162 |
ACUTE LEUKAEMIA |
12 |
0.0074 |
| 163 |
HYPERTROPHY |
4 |
0.0074 |
| 164 |
MUCORMYCOSIS |
19 |
0.0073 |
| 165 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
56 |
0.0073 |
| 166 |
HYPOFIBRINOGENAEMIA |
7 |
0.0071 |
| 167 |
VIRAL HAEMORRHAGIC CYSTITIS |
5 |
0.0070 |
| 168 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
31 |
0.0070 |
| 169 |
THROMBOSIS IN DEVICE |
23 |
0.0070 |
| 170 |
MENINGITIS BACTERIAL |
10 |
0.0070 |
| 171 |
LYMPHOCYTE MORPHOLOGY ABNORMAL |
4 |
0.0069 |
| 172 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
52 |
0.0069 |
| 173 |
BLOOD IMMUNOGLOBULIN G DECREASED |
17 |
0.0069 |
| 174 |
MONOCYTE COUNT DECREASED |
8 |
0.0066 |
| 175 |
CEREBRAL ASPERGILLOSIS |
4 |
0.0065 |
| 176 |
THERAPY NON-RESPONDER |
291 |
0.0065 |
| 177 |
PERIPHERAL MOTOR NEUROPATHY |
9 |
0.0064 |
| 178 |
INTENSIVE CARE |
9 |
0.0063 |
| 179 |
HYPOPROTEINAEMIA |
12 |
0.0063 |
| 180 |
NEUTROPENIC COLITIS |
13 |
0.0063 |
| 181 |
ASPERGILLUS INFECTION |
41 |
0.0062 |
| 182 |
DEVICE RELATED INFECTION |
96 |
0.0062 |
| 183 |
CARDIAC VENTRICULAR THROMBOSIS |
8 |
0.0062 |
| 184 |
VASCULAR ACCESS COMPLICATION |
5 |
0.0062 |
| 185 |
RHINOVIRUS INFECTION |
24 |
0.0062 |
| 186 |
ANGIOCENTRIC LYMPHOMA |
3 |
0.0061 |
| 187 |
SYSTEMIC CANDIDA |
15 |
0.0060 |
| 188 |
MARROW HYPERPLASIA |
4 |
0.0059 |
| 189 |
T-LYMPHOCYTE COUNT DECREASED |
4 |
0.0059 |
| 190 |
PSEUDOMONAL BACTERAEMIA |
5 |
0.0059 |
| 191 |
HEPATOTOXICITY |
130 |
0.0058 |
| 192 |
ENCEPHALOPATHY |
142 |
0.0058 |
| 193 |
JUGULAR VEIN THROMBOSIS |
10 |
0.0056 |
| 194 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
4 |
0.0056 |
| 195 |
STAPHYLOCOCCAL BACTERAEMIA |
24 |
0.0055 |
| 196 |
MUTISM |
8 |
0.0055 |
| 197 |
SYSTEMIC SCLERODERMA |
4 |
0.0055 |
| 198 |
CYTOMEGALOVIRUS INFECTION |
91 |
0.0055 |
| 199 |
TRANSPLANT |
13 |
0.0055 |
| 200 |
SPINAL CORD DISORDER |
9 |
0.0055 |
| 201 |
NERVOUS SYSTEM DISORDER |
167 |
0.0053 |
| 202 |
ACQUIRED GENE MUTATION |
7 |
0.0053 |
| 203 |
KLEBSIELLA SEPSIS |
6 |
0.0053 |
| 204 |
HUMAN HERPESVIRUS 6 INFECTION |
10 |
0.0053 |
| 205 |
NEUTROPENIC INFECTION |
5 |
0.0052 |
| 206 |
BLOOD CHLORIDE INCREASED |
9 |
0.0052 |
| 207 |
CYSTITIS HAEMORRHAGIC |
21 |
0.0052 |
| 208 |
PRODUCT PREPARATION ERROR |
107 |
0.0052 |
| 209 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
4 |
0.0052 |
| 210 |
SUPERINFECTION BACTERIAL |
4 |
0.0050 |
| 211 |
DYSGRAPHIA |
33 |
0.0050 |
| 212 |
THERAPEUTIC RESPONSE DELAYED |
14 |
0.0050 |
| 213 |
SINUSITIS FUNGAL |
4 |
0.0050 |
| 214 |
DEVICE RELATED SEPSIS |
10 |
0.0050 |
| 215 |
CLOSTRIDIUM COLITIS |
6 |
0.0049 |
| 216 |
BLAST CRISIS IN MYELOGENOUS LEUKAEMIA |
6 |
0.0049 |
| 217 |
QUADRIPLEGIA |
10 |
0.0049 |
| 218 |
CSF PROTEIN INCREASED |
4 |
0.0048 |
| 219 |
FUNGAL SEPSIS |
4 |
0.0048 |
| 220 |
STEM CELL TRANSPLANT |
12 |
0.0048 |
| 221 |
ARTERITIS |
3 |
0.0047 |
| 222 |
CEREBRAL VENOUS SINUS THROMBOSIS |
4 |
0.0047 |
| 223 |
FEBRILE NEUTROPENIA |
313 |
0.0047 |
| 224 |
POLYOMAVIRUS VIRAEMIA |
5 |
0.0047 |
| 225 |
DISSEMINATED INTRAVASCULAR COAGULATION |
66 |
0.0047 |
| 226 |
BACTERIAL SEPSIS |
15 |
0.0046 |
| 227 |
APHASIA |
139 |
0.0046 |
| 228 |
PARAINFLUENZAE VIRUS INFECTION |
7 |
0.0046 |
| 229 |
HAEMORRHAGIC DISORDER |
5 |
0.0046 |
| 230 |
STREPTOCOCCAL BACTERAEMIA |
5 |
0.0046 |
| 231 |
PSEUDOMONAL SEPSIS |
8 |
0.0046 |
| 232 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
23 |
0.0045 |
| 233 |
INTERCEPTED MEDICATION ERROR |
21 |
0.0045 |
| 234 |
ESCHERICHIA SEPSIS |
13 |
0.0045 |
| 235 |
CANDIDA SEPSIS |
4 |
0.0045 |
| 236 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
149 |
0.0044 |
| 237 |
CATHETER SITE HAEMORRHAGE |
11 |
0.0044 |
| 238 |
CENTRAL NERVOUS SYSTEM INFECTION |
5 |
0.0044 |
| 239 |
SERUM FERRITIN INCREASED |
23 |
0.0044 |
| 240 |
BODY TEMPERATURE ABNORMAL |
8 |
0.0043 |
| 241 |
BLOOD CULTURE POSITIVE |
13 |
0.0043 |
| 242 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
4 |
0.0043 |
| 243 |
C-REACTIVE PROTEIN |
4 |
0.0043 |
| 244 |
PRURITUS ALLERGIC |
5 |
0.0043 |
| 245 |
HYPORESPONSIVE TO STIMULI |
5 |
0.0043 |
| 246 |
ESCHERICHIA URINARY TRACT INFECTION |
18 |
0.0042 |
| 247 |
MYELOPATHY |
8 |
0.0042 |
| 248 |
NEUTROPENIC SEPSIS |
30 |
0.0042 |
| 249 |
ESCHERICHIA TEST POSITIVE |
5 |
0.0042 |
| 250 |
ENTEROBACTER INFECTION |
7 |
0.0042 |
| 251 |
SECONDARY IMMUNODEFICIENCY |
5 |
0.0041 |
| 252 |
PERIPHERAL SENSORY NEUROPATHY |
24 |
0.0041 |
| 253 |
MYELOSUPPRESSION |
143 |
0.0040 |
| 254 |
DILATED CARDIOMYOPATHY |
4 |
0.0040 |
| 255 |
ENTEROCOCCAL INFECTION |
19 |
0.0039 |
| 256 |
HAEMANGIOMA |
9 |
0.0039 |
| 257 |
HAEMATOTOXICITY |
37 |
0.0039 |
| 258 |
BACTERAEMIA |
46 |
0.0039 |
| 259 |
POSTICTAL STATE |
4 |
0.0038 |
| 260 |
SOFT TISSUE INFECTION |
7 |
0.0038 |
| 261 |
OBLITERATIVE BRONCHIOLITIS |
5 |
0.0038 |
| 262 |
HYPERAMMONAEMIA |
19 |
0.0038 |
| 263 |
THROMBOTIC MICROANGIOPATHY |
37 |
0.0038 |
| 264 |
EXTRADURAL HAEMATOMA |
5 |
0.0038 |
| 265 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
8 |
0.0037 |
| 266 |
PERIODONTITIS |
8 |
0.0037 |
| 267 |
STENOTROPHOMONAS INFECTION |
5 |
0.0037 |
| 268 |
KIDNEY ENLARGEMENT |
4 |
0.0037 |
| 269 |
METABOLIC ENCEPHALOPATHY |
11 |
0.0037 |
| 270 |
THERAPY PARTIAL RESPONDER |
57 |
0.0037 |
| 271 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
103 |
0.0036 |
| 272 |
EPSTEIN-BARR VIRAEMIA |
4 |
0.0036 |
| 273 |
HYPERTRIGLYCERIDAEMIA |
21 |
0.0036 |
| 274 |
TONIC CONVULSION |
5 |
0.0035 |
| 275 |
PNEUMATOSIS INTESTINALIS |
10 |
0.0035 |
| 276 |
CARDIOTOXICITY |
31 |
0.0035 |
| 277 |
NEUROLOGICAL DECOMPENSATION |
8 |
0.0035 |
| 278 |
PYREXIA |
1187 |
0.0034 |
| 279 |
RADICULOPATHY |
9 |
0.0034 |
| 280 |
BONE MARROW FAILURE |
69 |
0.0034 |
| 281 |
BRAIN HERNIATION |
10 |
0.0033 |
| 282 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
53 |
0.0033 |
| 283 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
5 |
0.0033 |
| 284 |
FEBRILE CONVULSION |
4 |
0.0033 |
| 285 |
PNEUMONIA KLEBSIELLA |
6 |
0.0033 |
| 286 |
LANGUAGE DISORDER |
7 |
0.0032 |
| 287 |
NEUTROPHIL COUNT ABNORMAL |
9 |
0.0032 |
| 288 |
PSEUDOMONAS INFECTION |
27 |
0.0031 |
| 289 |
TRANSAMINASES INCREASED |
70 |
0.0031 |
| 290 |
PNEUMONIA VIRAL |
10 |
0.0031 |
| 291 |
HEPATOSPLENOMEGALY |
8 |
0.0031 |
| 292 |
BRONCHOPULMONARY ASPERGILLOSIS |
24 |
0.0031 |
| 293 |
VASCULAR DEVICE INFECTION |
14 |
0.0031 |
| 294 |
HERPES SIMPLEX |
20 |
0.0031 |
| 295 |
NEUTROPHIL COUNT DECREASED |
125 |
0.0031 |
| 296 |
APLASIA |
6 |
0.0031 |
| 297 |
BONE LESION |
11 |
0.0030 |
| 298 |
CYTOMEGALOVIRUS COLITIS |
7 |
0.0030 |
| 299 |
GENERALISED TONIC-CLONIC SEIZURE |
50 |
0.0030 |
| 300 |
HYPERTRANSAMINASAEMIA |
21 |
0.0030 |
| 301 |
PANCREATITIS CHRONIC |
7 |
0.0030 |
| 302 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
9 |
0.0029 |
| 303 |
VIRAEMIA |
4 |
0.0029 |
| 304 |
LUNG CONSOLIDATION |
8 |
0.0029 |
| 305 |
PRODUCT LEAKAGE |
16 |
0.0028 |
| 306 |
ALANINE AMINOTRANSFERASE ABNORMAL |
6 |
0.0028 |
| 307 |
DEVICE CONNECTION ISSUE |
6 |
0.0028 |
| 308 |
WHITE BLOOD CELL COUNT ABNORMAL |
18 |
0.0028 |
| 309 |
PANCYTOPENIA |
157 |
0.0028 |
| 310 |
TRANSPLANT DYSFUNCTION |
5 |
0.0028 |
| 311 |
ATAXIA |
33 |
0.0028 |
| 312 |
OLIGURIA |
17 |
0.0027 |
| 313 |
AMYLASE INCREASED |
10 |
0.0027 |
| 314 |
BLOOD BILIRUBIN INCREASED |
73 |
0.0027 |
| 315 |
FACIAL PARALYSIS |
23 |
0.0027 |
| 316 |
INTRACRANIAL PRESSURE INCREASED |
15 |
0.0027 |
| 317 |
MENINGITIS ASEPTIC |
12 |
0.0027 |
| 318 |
CATHETER SITE INFECTION |
10 |
0.0026 |
| 319 |
BONE MARROW TRANSPLANT |
5 |
0.0026 |
| 320 |
ARTERIAL HAEMORRHAGE |
3 |
0.0026 |
| 321 |
LIVER FUNCTION TEST INCREASED |
56 |
0.0026 |
| 322 |
GASTROINTESTINAL INJURY |
7 |
0.0026 |
| 323 |
LYMPHOCYTE COUNT DECREASED |
46 |
0.0026 |
| 324 |
HYPERPYREXIA |
11 |
0.0026 |
| 325 |
INFERTILITY FEMALE |
4 |
0.0026 |
| 326 |
CORONAVIRUS INFECTION |
17 |
0.0026 |
| 327 |
BILIRUBIN CONJUGATED INCREASED |
6 |
0.0026 |
| 328 |
SUBDURAL HAEMORRHAGE |
7 |
0.0026 |
| 329 |
FIBRIN D DIMER INCREASED |
9 |
0.0025 |
| 330 |
CELL DEATH |
5 |
0.0025 |
| 331 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
25 |
0.0025 |
| 332 |
PLATELET COUNT ABNORMAL |
15 |
0.0025 |
| 333 |
STATUS EPILEPTICUS |
28 |
0.0025 |
| 334 |
SCLERODERMA |
9 |
0.0025 |
| 335 |
CYTOMEGALOVIRUS VIRAEMIA |
11 |
0.0025 |
| 336 |
VENTRICULAR ARRHYTHMIA |
9 |
0.0025 |
| 337 |
CLOSTRIDIUM DIFFICILE COLITIS |
26 |
0.0024 |
| 338 |
LYMPHOCYTE COUNT INCREASED |
8 |
0.0024 |
| 339 |
NEUTROPENIA |
333 |
0.0024 |
| 340 |
ATRIAL THROMBOSIS |
5 |
0.0024 |
| 341 |
DEVICE OCCLUSION |
34 |
0.0024 |
| 342 |
SEIZURE |
279 |
0.0024 |
| 343 |
RED CELL DISTRIBUTION WIDTH INCREASED |
10 |
0.0024 |
| 344 |
DISEASE COMPLICATION |
11 |
0.0024 |
| 345 |
PULSELESS ELECTRICAL ACTIVITY |
10 |
0.0024 |
| 346 |
KLEBSIELLA INFECTION |
12 |
0.0024 |
| 347 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
9 |
0.0024 |
| 348 |
GAZE PALSY |
4 |
0.0023 |
| 349 |
LACTOSE INTOLERANCE |
6 |
0.0023 |
| 350 |
ADVERSE REACTION |
31 |
0.0023 |
| 351 |
MUCOSAL INFLAMMATION |
61 |
0.0023 |
| 352 |
CEREBROVASCULAR DISORDER |
7 |
0.0023 |
| 353 |
BONE MARROW DISORDER |
7 |
0.0023 |
| 354 |
ENCEPHALITIS |
16 |
0.0023 |
| 355 |
GASTROINTESTINAL TOXICITY |
11 |
0.0023 |
| 356 |
EMBOLISM |
19 |
0.0023 |
| 357 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
5 |
0.0023 |
| 358 |
ANION GAP INCREASED |
3 |
0.0022 |
| 359 |
PRODUCT STORAGE ERROR |
196 |
0.0022 |
| 360 |
ORGANISING PNEUMONIA |
11 |
0.0022 |
| 361 |
PAPILLOEDEMA |
10 |
0.0022 |
| 362 |
MONOPARESIS |
4 |
0.0022 |
| 363 |
HEPATITIS B REACTIVATION |
7 |
0.0022 |
| 364 |
METASTASES TO MENINGES |
5 |
0.0022 |
| 365 |
MENTAL STATUS CHANGES |
61 |
0.0022 |
| 366 |
APNOEA |
17 |
0.0022 |
| 367 |
THROMBOCYTOPENIA |
234 |
0.0021 |
| 368 |
SLOW SPEECH |
5 |
0.0021 |
| 369 |
PNEUMONIA CYTOMEGALOVIRAL |
4 |
0.0021 |
| 370 |
PULMONARY HAEMORRHAGE |
16 |
0.0020 |
| 371 |
COVID-19 PNEUMONIA |
24 |
0.0020 |
| 372 |
DRUG RESISTANCE |
52 |
0.0020 |
| 373 |
ACUTE PSYCHOSIS |
5 |
0.0020 |
| 374 |
ALANINE AMINOTRANSFERASE INCREASED |
124 |
0.0020 |
| 375 |
HEPATIC FUNCTION ABNORMAL |
75 |
0.0020 |
| 376 |
PROTHROMBIN TIME PROLONGED |
12 |
0.0020 |
| 377 |
FACIAL PARESIS |
7 |
0.0020 |
| 378 |
SHOCK HAEMORRHAGIC |
16 |
0.0020 |
| 379 |
ENDOCARDITIS |
10 |
0.0019 |
| 380 |
DIFFUSE LARGE B-CELL LYMPHOMA |
15 |
0.0019 |
| 381 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
57 |
0.0019 |
| 382 |
ALTERED STATE OF CONSCIOUSNESS |
42 |
0.0019 |
| 383 |
HYPERBILIRUBINAEMIA |
20 |
0.0019 |
| 384 |
VARICELLA ZOSTER VIRUS INFECTION |
4 |
0.0019 |
| 385 |
ACCIDENTAL EXPOSURE TO PRODUCT |
198 |
0.0019 |
| 386 |
LYMPHOPENIA |
27 |
0.0019 |
| 387 |
STAPHYLOCOCCUS TEST POSITIVE |
4 |
0.0019 |
| 388 |
LUNG OPACITY |
5 |
0.0019 |
| 389 |
NON-CARDIAC CHEST PAIN |
6 |
0.0019 |
| 390 |
CARDIAC DYSFUNCTION |
7 |
0.0019 |
| 391 |
PROTEIN TOTAL DECREASED |
7 |
0.0019 |
| 392 |
INFECTION |
268 |
0.0018 |
| 393 |
HYPOXIA |
65 |
0.0018 |
| 394 |
FULL BLOOD COUNT DECREASED |
37 |
0.0018 |
| 395 |
CEREBELLAR SYNDROME |
4 |
0.0018 |
| 396 |
STAPHYLOCOCCAL SEPSIS |
9 |
0.0018 |
| 397 |
HEPATIC ENCEPHALOPATHY |
17 |
0.0018 |
| 398 |
HAEMOLYSIS |
14 |
0.0018 |
| 399 |
PLEURITIC PAIN |
5 |
0.0018 |
| 400 |
HYPOALBUMINAEMIA |
14 |
0.0018 |
| 401 |
ACUTE MYELOID LEUKAEMIA |
28 |
0.0018 |
| 402 |
ILEUS PARALYTIC |
8 |
0.0018 |
| 403 |
DISORIENTATION |
71 |
0.0018 |
| 404 |
HYPERGLYCAEMIA |
65 |
0.0018 |
| 405 |
ENDOTRACHEAL INTUBATION |
5 |
0.0018 |
| 406 |
EPSTEIN-BARR VIRUS INFECTION |
11 |
0.0018 |
| 407 |
DELIRIUM |
61 |
0.0018 |
| 408 |
BRAIN OEDEMA |
22 |
0.0017 |
| 409 |
ENTEROCOLITIS |
10 |
0.0017 |
| 410 |
TREMOR |
287 |
0.0017 |
| 411 |
SEPSIS |
192 |
0.0017 |
| 412 |
WHITE BLOOD CELL COUNT INCREASED |
66 |
0.0017 |
| 413 |
PARTIAL SEIZURES |
9 |
0.0017 |
| 414 |
RESPIRATORY TRACT INFECTION VIRAL |
4 |
0.0017 |
| 415 |
BLOOD LACTIC ACID INCREASED |
9 |
0.0017 |
| 416 |
HYPERURICAEMIA |
7 |
0.0017 |
| 417 |
LUNG INFILTRATION |
15 |
0.0017 |
| 418 |
LEUKAEMIA |
16 |
0.0017 |
| 419 |
DISEASE RECURRENCE |
80 |
0.0017 |
| 420 |
INTRA-ABDOMINAL HAEMORRHAGE |
4 |
0.0017 |
| 421 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
16 |
0.0017 |
| 422 |
DYSARTHRIA |
63 |
0.0017 |
| 423 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
37 |
0.0017 |
| 424 |
SEPTIC SHOCK |
72 |
0.0017 |
| 425 |
CUTANEOUS VASCULITIS |
6 |
0.0016 |
| 426 |
PRODUCT CONTAINER ISSUE |
14 |
0.0016 |
| 427 |
HYPOPHOSPHATAEMIA |
12 |
0.0016 |
| 428 |
DISEASE PROGRESSION |
192 |
0.0016 |
| 429 |
ASPARTATE AMINOTRANSFERASE INCREASED |
86 |
0.0016 |
| 430 |
NEOPLASM PROGRESSION |
56 |
0.0016 |
| 431 |
HEMIPARESIS |
27 |
0.0016 |
| 432 |
ELECTROENCEPHALOGRAM ABNORMAL |
5 |
0.0016 |
| 433 |
COMMUNICATION DISORDER |
6 |
0.0016 |
| 434 |
BODY TEMPERATURE INCREASED |
32 |
0.0016 |
| 435 |
LIPASE INCREASED |
12 |
0.0016 |
| 436 |
ABDOMINAL INFECTION |
4 |
0.0016 |
| 437 |
SECOND PRIMARY MALIGNANCY |
13 |
0.0016 |
| 438 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
8 |
0.0016 |
| 439 |
PULMONARY TOXICITY |
11 |
0.0016 |
| 440 |
PORTAL VEIN THROMBOSIS |
5 |
0.0015 |
| 441 |
HAEMORRHAGE INTRACRANIAL |
23 |
0.0015 |
| 442 |
EPILEPSY |
47 |
0.0015 |
| 443 |
HEPATITIS TOXIC |
4 |
0.0015 |
| 444 |
PRODUCT ADMINISTRATION INTERRUPTED |
12 |
0.0015 |
| 445 |
MYELODYSPLASTIC SYNDROME |
22 |
0.0015 |
| 446 |
PLEURAL EFFUSION |
92 |
0.0015 |
| 447 |
CEREBRAL ATROPHY |
6 |
0.0015 |
| 448 |
PROTEIN TOTAL INCREASED |
4 |
0.0015 |
| 449 |
PLATELET COUNT DECREASED |
160 |
0.0015 |
| 450 |
COAGULOPATHY |
25 |
0.0015 |
| 451 |
WHITE BLOOD CELL DISORDER |
4 |
0.0015 |
| 452 |
ORGAN FAILURE |
6 |
0.0015 |
| 453 |
SUBARACHNOID HAEMORRHAGE |
15 |
0.0015 |
| 454 |
RECURRENT CANCER |
6 |
0.0015 |
| 455 |
INFUSION SITE EXTRAVASATION |
9 |
0.0014 |
| 456 |
CONFUSIONAL STATE |
232 |
0.0014 |
| 457 |
HEPATIC FAILURE |
43 |
0.0014 |
| 458 |
PULMONARY ALVEOLAR HAEMORRHAGE |
8 |
0.0014 |
| 459 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
25 |
0.0014 |
| 460 |
HEPATIC CYTOLYSIS |
18 |
0.0014 |
| 461 |
ACUTE RESPIRATORY FAILURE |
27 |
0.0014 |
| 462 |
TREATMENT FAILURE |
116 |
0.0014 |
| 463 |
SUBDURAL HAEMATOMA |
20 |
0.0014 |
| 464 |
BLOOD ALBUMIN DECREASED |
11 |
0.0014 |
| 465 |
BLOOD URIC ACID INCREASED |
8 |
0.0014 |
| 466 |
TOXIC ENCEPHALOPATHY |
7 |
0.0014 |
| 467 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
7 |
0.0014 |
| 468 |
C-REACTIVE PROTEIN INCREASED |
50 |
0.0014 |
| 469 |
SPLENOMEGALY |
16 |
0.0014 |
| 470 |
CANDIDA INFECTION |
23 |
0.0014 |
| 471 |
IMMUNOSUPPRESSION |
12 |
0.0014 |
| 472 |
CEREBRAL ISCHAEMIA |
7 |
0.0014 |
| 473 |
NEURODERMATITIS |
5 |
0.0013 |
| 474 |
PERICARDIAL EFFUSION |
31 |
0.0013 |
| 475 |
HEPATIC NECROSIS |
5 |
0.0013 |
| 476 |
HEPATOMEGALY |
13 |
0.0013 |
| 477 |
CHEMOTHERAPY |
5 |
0.0013 |
| 478 |
HYPOKALAEMIA |
61 |
0.0013 |
| 479 |
FUNGAL INFECTION |
44 |
0.0013 |
| 480 |
NEUROPATHY PERIPHERAL |
125 |
0.0013 |
| 481 |
IMMUNE THROMBOCYTOPENIA |
6 |
0.0013 |
| 482 |
CHRONIC MYELOID LEUKAEMIA |
6 |
0.0013 |
| 483 |
BACTERIAL INFECTION |
24 |
0.0013 |
| 484 |
CEREBRAL HAEMORRHAGE |
46 |
0.0013 |
| 485 |
SPINAL CORD COMPRESSION |
5 |
0.0013 |
| 486 |
TUBULOINTERSTITIAL NEPHRITIS |
24 |
0.0013 |
| 487 |
LEUKOPENIA |
64 |
0.0013 |
| 488 |
BLOOD CREATININE DECREASED |
4 |
0.0013 |
| 489 |
HYPOCALCAEMIA |
24 |
0.0013 |
| 490 |
LIVER INJURY |
31 |
0.0013 |
| 491 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
6 |
0.0013 |
| 492 |
CHOLESTASIS |
24 |
0.0012 |
| 493 |
INCONTINENCE |
13 |
0.0012 |
| 494 |
ARTERIOSCLEROSIS CORONARY ARTERY |
8 |
0.0012 |
| 495 |
END STAGE RENAL DISEASE |
22 |
0.0012 |
| 496 |
CLOSTRIDIUM DIFFICILE INFECTION |
26 |
0.0012 |
| 497 |
BLOOD COUNT ABNORMAL |
18 |
0.0012 |
| 498 |
DYSPHORIA |
6 |
0.0012 |
| 499 |
STAPHYLOCOCCAL INFECTION |
39 |
0.0012 |
| 500 |
PETIT MAL EPILEPSY |
6 |
0.0012 |
| 501 |
TACHYCARDIA |
104 |
0.0012 |
| 502 |
BLOOD CREATININE ABNORMAL |
4 |
0.0012 |
| 503 |
LABORATORY TEST ABNORMAL |
34 |
0.0012 |
| 504 |
UNEVALUABLE EVENT |
87 |
0.0011 |
| 505 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
10 |
0.0011 |
| 506 |
HEPATIC ENZYME INCREASED |
78 |
0.0011 |
| 507 |
EOSINOPHILIA |
20 |
0.0011 |
| 508 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
28 |
0.0011 |
| 509 |
ASCITES |
33 |
0.0011 |
| 510 |
DECREASED IMMUNE RESPONSIVENESS |
11 |
0.0011 |
| 511 |
COMPRESSION FRACTURE |
6 |
0.0011 |
| 512 |
RESPIRATORY FAILURE |
81 |
0.0011 |
| 513 |
LIVER DISORDER |
49 |
0.0011 |
| 514 |
COMPLICATION ASSOCIATED WITH DEVICE |
16 |
0.0011 |
| 515 |
HICCUPS |
9 |
0.0011 |
| 516 |
STOMATITIS |
66 |
0.0011 |
| 517 |
HAEMOGLOBIN ABNORMAL |
7 |
0.0011 |
| 518 |
IMMUNODEFICIENCY |
16 |
0.0011 |
| 519 |
MALNUTRITION |
12 |
0.0011 |
| 520 |
REFUSAL OF TREATMENT BY PATIENT |
7 |
0.0011 |
| 521 |
PANCREATITIS |
56 |
0.0011 |
| 522 |
GLOMERULAR FILTRATION RATE DECREASED |
13 |
0.0011 |
| 523 |
PERONEAL NERVE PALSY |
6 |
0.0011 |
| 524 |
GRANULOCYTOPENIA |
6 |
0.0011 |
| 525 |
LEUKOCYTOSIS |
19 |
0.0010 |
| 526 |
MENINGITIS |
7 |
0.0010 |
| 527 |
WHITE BLOOD CELL COUNT DECREASED |
113 |
0.0010 |
| 528 |
MYOPATHY |
9 |
0.0010 |
| 529 |
PRODUCT ADMINISTRATION ERROR |
21 |
0.0010 |
| 530 |
BLOOD CALCIUM INCREASED |
9 |
0.0010 |
| 531 |
ADVERSE EVENT |
94 |
0.0010 |
| 532 |
GASTROINTESTINAL INFECTION |
9 |
0.0010 |
| 533 |
HEPATIC ENZYME ABNORMAL |
5 |
0.0010 |
| 534 |
CORONARY ARTERY STENOSIS |
5 |
0.0010 |
| 535 |
OPTIC NEURITIS |
9 |
0.0010 |
| 536 |
AMMONIA INCREASED |
5 |
0.0010 |
| 537 |
ARTHRITIS BACTERIAL |
4 |
0.0010 |
| 538 |
SPEECH DISORDER |
51 |
0.0010 |
| 539 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
8 |
0.0010 |
| 540 |
UNRESPONSIVE TO STIMULI |
25 |
0.0010 |
| 541 |
CHOLANGITIS |
6 |
0.0010 |
| 542 |
MUSCLE TWITCHING |
22 |
0.0010 |
| 543 |
METASTASES TO LUNG |
11 |
0.0010 |
| 544 |
COLITIS |
36 |
0.0009 |
| 545 |
OSTEONECROSIS OF JAW |
23 |
0.0009 |
| 546 |
HYDROCEPHALUS |
5 |
0.0009 |
| 547 |
SHOCK |
21 |
0.0009 |
| 548 |
CARDIOGENIC SHOCK |
13 |
0.0009 |
| 549 |
OFF LABEL USE |
793 |
0.0009 |
| 550 |
NO THERAPEUTIC RESPONSE |
11 |
0.0009 |
| 551 |
CARDIAC FAILURE ACUTE |
6 |
0.0009 |
| 552 |
LEFT VENTRICULAR DYSFUNCTION |
6 |
0.0009 |
| 553 |
NEPHROPATHY TOXIC |
10 |
0.0009 |
| 554 |
HYPERCALCAEMIA |
11 |
0.0009 |
| 555 |
ANAL INCONTINENCE |
8 |
0.0009 |
| 556 |
HYPOTHERMIA |
9 |
0.0009 |
| 557 |
CHILLS |
104 |
0.0009 |
| 558 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
35 |
0.0009 |
| 559 |
ACUTE HEPATIC FAILURE |
12 |
0.0009 |
| 560 |
DRUG EFFECT LESS THAN EXPECTED |
13 |
0.0009 |
| 561 |
LARGE INTESTINE PERFORATION |
6 |
0.0009 |
| 562 |
RALES |
5 |
0.0009 |
| 563 |
ANAEMIA |
164 |
0.0009 |
| 564 |
PRODUCT LABEL CONFUSION |
5 |
0.0009 |
| 565 |
RASH MACULO-PAPULAR |
19 |
0.0009 |
| 566 |
ESCHERICHIA INFECTION |
7 |
0.0009 |
| 567 |
PANCREATITIS ACUTE |
19 |
0.0008 |
| 568 |
SINUS TACHYCARDIA |
12 |
0.0008 |
| 569 |
MUSCLE INJURY |
7 |
0.0008 |
| 570 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
4 |
0.0008 |
| 571 |
LUNG INFECTION |
13 |
0.0008 |
| 572 |
HYPOVOLAEMIC SHOCK |
4 |
0.0008 |
| 573 |
RESPIRATORY DISTRESS |
23 |
0.0008 |
| 574 |
HEPATITIS B |
5 |
0.0008 |
| 575 |
GUILLAIN-BARRE SYNDROME |
4 |
0.0008 |
| 576 |
BONE PAIN |
48 |
0.0008 |
| 577 |
HYPOTENSION |
162 |
0.0008 |
| 578 |
ILEUS |
10 |
0.0008 |
| 579 |
SKIN INFECTION |
9 |
0.0008 |
| 580 |
HYPOMAGNESAEMIA |
11 |
0.0008 |
| 581 |
HYPERTHERMIA |
6 |
0.0008 |
| 582 |
DEATH |
674 |
0.0008 |
| 583 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
8 |
0.0008 |
| 584 |
TORSADE DE POINTES |
6 |
0.0008 |
| 585 |
LYMPHADENOPATHY |
27 |
0.0008 |
| 586 |
PRODUCT PREPARATION ISSUE |
5 |
0.0008 |
| 587 |
SARS-COV-2 TEST POSITIVE |
10 |
0.0008 |
| 588 |
FULL BLOOD COUNT ABNORMAL |
8 |
0.0008 |
| 589 |
POLYNEUROPATHY |
9 |
0.0008 |
| 590 |
TRANSPLANT REJECTION |
6 |
0.0007 |
| 591 |
POST PROCEDURAL INFECTION |
6 |
0.0007 |
| 592 |
TACHYPNOEA |
10 |
0.0007 |
| 593 |
HYPERKERATOSIS |
4 |
0.0007 |
| 594 |
HEMIPLEGIA |
6 |
0.0007 |
| 595 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
51 |
0.0007 |
| 596 |
RENAL IMPAIRMENT |
60 |
0.0007 |
| 597 |
ACUTE PULMONARY OEDEMA |
4 |
0.0007 |
| 598 |
FACE OEDEMA |
12 |
0.0007 |
| 599 |
HEPATOCELLULAR INJURY |
10 |
0.0007 |
| 600 |
ABSCESS LIMB |
3 |
0.0007 |
| 601 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
142 |
0.0007 |
| 602 |
PNEUMONITIS |
19 |
0.0007 |
| 603 |
PNEUMOTHORAX |
11 |
0.0007 |
| 604 |
PULMONARY OEDEMA |
31 |
0.0007 |
| 605 |
ORAL CANDIDIASIS |
9 |
0.0007 |
| 606 |
DECREASED INTEREST |
4 |
0.0007 |
| 607 |
HAEMOLYTIC ANAEMIA |
6 |
0.0007 |
| 608 |
DRUG-INDUCED LIVER INJURY |
21 |
0.0007 |
| 609 |
VENTRICULAR TACHYCARDIA |
11 |
0.0007 |
| 610 |
COGNITIVE DISORDER |
31 |
0.0007 |
| 611 |
ADRENAL INSUFFICIENCY |
8 |
0.0007 |
| 612 |
TROPONIN INCREASED |
5 |
0.0007 |
| 613 |
HAEMODYNAMIC INSTABILITY |
5 |
0.0007 |
| 614 |
CENTRAL NERVOUS SYSTEM LESION |
9 |
0.0007 |
| 615 |
UPPER RESPIRATORY TRACT INFECTION |
30 |
0.0006 |
| 616 |
MALIGNANT NEOPLASM PROGRESSION |
66 |
0.0006 |
| 617 |
APPENDICITIS |
6 |
0.0006 |
| 618 |
INTERSTITIAL LUNG DISEASE |
31 |
0.0006 |
| 619 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
35 |
0.0006 |
| 620 |
HOSPITALISATION |
98 |
0.0006 |
| 621 |
GINGIVAL PAIN |
5 |
0.0006 |
| 622 |
COVID-19 |
110 |
0.0006 |
| 623 |
SUPRAVENTRICULAR TACHYCARDIA |
6 |
0.0006 |
| 624 |
METASTASES TO LIVER |
11 |
0.0006 |
| 625 |
ENTERITIS |
4 |
0.0006 |
| 626 |
PNEUMONIA |
201 |
0.0006 |
| 627 |
MENTAL DISORDER |
27 |
0.0006 |
| 628 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
8 |
0.0006 |
| 629 |
LIVER FUNCTION TEST ABNORMAL |
18 |
0.0006 |
| 630 |
INCOHERENT |
4 |
0.0006 |
| 631 |
NEURALGIA |
15 |
0.0006 |
| 632 |
BRADYPHRENIA |
4 |
0.0006 |
| 633 |
NEOPLASM |
7 |
0.0006 |
| 634 |
HOSPICE CARE |
6 |
0.0006 |
| 635 |
HEADACHE |
379 |
0.0006 |
| 636 |
DRUG LEVEL INCREASED |
10 |
0.0006 |
| 637 |
PERICARDITIS |
10 |
0.0006 |
| 638 |
AGRANULOCYTOSIS |
11 |
0.0006 |
| 639 |
MELAENA |
13 |
0.0006 |
| 640 |
MOTOR DYSFUNCTION |
6 |
0.0006 |
| 641 |
ACUTE KIDNEY INJURY |
90 |
0.0006 |
| 642 |
CHOLECYSTITIS |
7 |
0.0006 |
| 643 |
CIRCULATORY COLLAPSE |
10 |
0.0006 |
| 644 |
MYOCLONUS |
7 |
0.0006 |
| 645 |
EUPHORIC MOOD |
6 |
0.0006 |
| 646 |
EYE MOVEMENT DISORDER |
4 |
0.0006 |
| 647 |
BLOOD MAGNESIUM DECREASED |
5 |
0.0006 |
| 648 |
APLASTIC ANAEMIA |
3 |
0.0006 |
| 649 |
DEMENTIA |
16 |
0.0006 |
| 650 |
MASS |
8 |
0.0006 |
| 651 |
OEDEMA |
31 |
0.0006 |
| 652 |
TOXICITY TO VARIOUS AGENTS |
96 |
0.0006 |
| 653 |
PAPULE |
4 |
0.0006 |
| 654 |
DRUG ERUPTION |
10 |
0.0006 |
| 655 |
ANAL ABSCESS |
3 |
0.0006 |
| 656 |
DEVICE LEAKAGE |
24 |
0.0006 |
| 657 |
LUNG DISORDER |
27 |
0.0006 |
| 658 |
PATHOGEN RESISTANCE |
5 |
0.0005 |
| 659 |
HEPATITIS |
14 |
0.0005 |
| 660 |
MOUTH HAEMORRHAGE |
4 |
0.0005 |
| 661 |
INFUSION RELATED REACTION |
36 |
0.0005 |
| 662 |
DRUG INTOLERANCE |
52 |
0.0005 |
| 663 |
RESPIRATORY TRACT INFECTION |
14 |
0.0005 |
| 664 |
ANGIOPATHY |
3 |
0.0005 |
| 665 |
HALLUCINATION |
40 |
0.0005 |
| 666 |
PULMONARY HYPERTENSION |
11 |
0.0005 |
| 667 |
ILL-DEFINED DISORDER |
32 |
0.0005 |
| 668 |
DISSOCIATION |
4 |
0.0005 |
| 669 |
PNEUMONIA ASPIRATION |
13 |
0.0005 |
| 670 |
LYMPHOMA |
8 |
0.0005 |
| 671 |
ELECTROLYTE IMBALANCE |
6 |
0.0005 |
| 672 |
BLOOD PRESSURE DECREASED |
34 |
0.0005 |
| 673 |
INFLAMMATORY BOWEL DISEASE |
5 |
0.0005 |
| 674 |
BLOOD TRIGLYCERIDES INCREASED |
9 |
0.0005 |
| 675 |
RHEUMATOID ARTHRITIS |
57 |
0.0005 |
| 676 |
COORDINATION ABNORMAL |
7 |
0.0005 |
| 677 |
MUSCULAR WEAKNESS |
57 |
0.0005 |
| 678 |
BLOOD DISORDER |
4 |
0.0005 |
| 679 |
OXYGEN SATURATION DECREASED |
28 |
0.0005 |
| 680 |
OSTEOMYELITIS |
9 |
0.0005 |
| 681 |
SKIN REACTION |
7 |
0.0005 |
| 682 |
DRUG EFFECT INCOMPLETE |
18 |
0.0005 |
| 683 |
LETHARGY |
28 |
0.0005 |
| 684 |
VENTRICULAR EXTRASYSTOLES |
5 |
0.0005 |
| 685 |
FLUID OVERLOAD |
7 |
0.0005 |
| 686 |
CARDIAC FAILURE |
38 |
0.0005 |
| 687 |
URINARY INCONTINENCE |
14 |
0.0005 |
| 688 |
SOMNOLENCE |
95 |
0.0005 |
| 689 |
PULMONARY MASS |
7 |
0.0005 |
| 690 |
HAEMATURIA |
16 |
0.0005 |
| 691 |
SKIN HYPERPIGMENTATION |
4 |
0.0005 |
| 692 |
EPISTAXIS |
34 |
0.0005 |
| 693 |
VIRAL INFECTION |
15 |
0.0005 |
| 694 |
CEREBRAL INFARCTION |
11 |
0.0004 |
| 695 |
VENTRICULAR FIBRILLATION |
5 |
0.0004 |
| 696 |
URINARY RETENTION |
15 |
0.0004 |
| 697 |
HAEMOGLOBIN DECREASED |
46 |
0.0004 |
| 698 |
DEEP VEIN THROMBOSIS |
29 |
0.0004 |
| 699 |
TRANSIENT ISCHAEMIC ATTACK |
15 |
0.0004 |
| 700 |
COMA |
21 |
0.0004 |
| 701 |
MYOCARDITIS |
5 |
0.0004 |
| 702 |
PNEUMONIA BACTERIAL |
4 |
0.0004 |
| 703 |
MUSCULOSKELETAL DISORDER |
8 |
0.0004 |
| 704 |
RED BLOOD CELL COUNT DECREASED |
12 |
0.0004 |
| 705 |
PARALYSIS |
6 |
0.0004 |
| 706 |
BLOOD UREA INCREASED |
7 |
0.0004 |
| 707 |
PULMONARY FIBROSIS |
8 |
0.0004 |
| 708 |
POST PROCEDURAL COMPLICATION |
8 |
0.0004 |
| 709 |
HYPERTENSION |
88 |
0.0004 |
| 710 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
9 |
0.0004 |
| 711 |
ATELECTASIS |
4 |
0.0004 |
| 712 |
SINUS BRADYCARDIA |
4 |
0.0004 |
| 713 |
INJECTION SITE HAEMORRHAGE |
33 |
0.0004 |
| 714 |
SCHIZOPHRENIA |
5 |
0.0004 |
| 715 |
AUTOIMMUNE DISORDER |
4 |
0.0004 |
| 716 |
VITAMIN D DEFICIENCY |
4 |
0.0004 |
| 717 |
ORAL HERPES |
8 |
0.0004 |
| 718 |
THERAPY CHANGE |
4 |
0.0004 |
| 719 |
RENAL INJURY |
12 |
0.0004 |
| 720 |
GENERALISED OEDEMA |
5 |
0.0004 |
| 721 |
HAEMATOCRIT DECREASED |
8 |
0.0004 |
| 722 |
LACTIC ACIDOSIS |
13 |
0.0004 |
| 723 |
OSTEOPENIA |
6 |
0.0004 |
| 724 |
AGITATION |
29 |
0.0004 |
| 725 |
EYELID PTOSIS |
4 |
0.0004 |
| 726 |
ACIDOSIS |
3 |
0.0004 |
| 727 |
HAEMORRHAGE |
41 |
0.0004 |
| 728 |
HYPOPHAGIA |
10 |
0.0004 |
| 729 |
TEMPERATURE INTOLERANCE |
4 |
0.0004 |
| 730 |
SKIN ULCER |
10 |
0.0004 |
| 731 |
APHTHOUS ULCER |
3 |
0.0004 |
| 732 |
EJECTION FRACTION DECREASED |
6 |
0.0004 |
| 733 |
BASAL CELL CARCINOMA |
6 |
0.0004 |
| 734 |
PETECHIAE |
4 |
0.0004 |
| 735 |
ARTERIAL OCCLUSIVE DISEASE |
3 |
0.0004 |
| 736 |
HYPOAESTHESIA |
57 |
0.0004 |
| 737 |
ADVERSE DRUG REACTION |
34 |
0.0004 |
| 738 |
JAUNDICE |
10 |
0.0004 |
| 739 |
THERAPY INTERRUPTED |
26 |
0.0004 |
| 740 |
PSYCHOMOTOR HYPERACTIVITY |
6 |
0.0004 |
| 741 |
BLOOD CALCIUM DECREASED |
4 |
0.0004 |
| 742 |
HYPONATRAEMIA |
20 |
0.0004 |
| 743 |
HAEMATEMESIS |
9 |
0.0004 |
| 744 |
GASTROENTERITIS |
5 |
0.0003 |
| 745 |
MOVEMENT DISORDER |
11 |
0.0003 |
| 746 |
MEMORY IMPAIRMENT |
47 |
0.0003 |
| 747 |
DRUG INEFFECTIVE |
448 |
0.0003 |
| 748 |
SYNCOPE |
34 |
0.0003 |
| 749 |
RASH |
148 |
0.0003 |
| 750 |
CARDIOMYOPATHY |
5 |
0.0003 |
| 751 |
CELLULITIS |
17 |
0.0003 |
| 752 |
GENERAL PHYSICAL HEALTH DETERIORATION |
39 |
0.0003 |
| 753 |
ISCHAEMIC STROKE |
6 |
0.0003 |
| 754 |
CHOLELITHIASIS |
11 |
0.0003 |
| 755 |
HYPERLIPIDAEMIA |
4 |
0.0003 |
| 756 |
BLOOD POTASSIUM DECREASED |
10 |
0.0003 |
| 757 |
MENTAL IMPAIRMENT |
8 |
0.0003 |
| 758 |
RESTLESSNESS |
12 |
0.0003 |
| 759 |
VOMITING |
153 |
0.0003 |
| 760 |
MUSCULOSKELETAL CHEST PAIN |
5 |
0.0003 |
| 761 |
BRADYCARDIA |
17 |
0.0003 |
| 762 |
ATRIAL FIBRILLATION |
31 |
0.0003 |
| 763 |
MYALGIA |
54 |
0.0003 |
| 764 |
ASTHENIA |
119 |
0.0003 |
| 765 |
PULMONARY EMBOLISM |
30 |
0.0003 |
| 766 |
HERPES ZOSTER |
18 |
0.0003 |
| 767 |
HEART RATE INCREASED |
31 |
0.0003 |
| 768 |
AFFECT LABILITY |
3 |
0.0003 |
| 769 |
CARDIO-RESPIRATORY ARREST |
13 |
0.0003 |
| 770 |
INFUSION SITE PAIN |
4 |
0.0003 |
| 771 |
INFLAMMATION |
16 |
0.0003 |
| 772 |
DYSTONIA |
6 |
0.0003 |
| 773 |
BLOOD CREATININE INCREASED |
20 |
0.0003 |
| 774 |
DEAFNESS |
8 |
0.0003 |
| 775 |
INCORRECT PRODUCT STORAGE |
4 |
0.0003 |
| 776 |
IMMUNE SYSTEM DISORDER |
4 |
0.0003 |
| 777 |
RENAL FAILURE |
40 |
0.0003 |
| 778 |
BALANCE DISORDER |
26 |
0.0003 |
| 779 |
THROMBOSIS |
24 |
0.0003 |
| 780 |
THERAPEUTIC RESPONSE DECREASED |
18 |
0.0003 |
| 781 |
FEEDING DISORDER |
6 |
0.0003 |
| 782 |
RASH ERYTHEMATOUS |
14 |
0.0003 |
| 783 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
13 |
0.0003 |
| 784 |
GASTROINTESTINAL DISORDER |
26 |
0.0003 |
| 785 |
FEELING COLD |
8 |
0.0003 |
| 786 |
APHONIA |
4 |
0.0003 |
| 787 |
HALLUCINATION, VISUAL |
6 |
0.0003 |
| 788 |
DIALYSIS |
4 |
0.0003 |
| 789 |
BRONCHOSPASM |
4 |
0.0003 |
| 790 |
PARAESTHESIA |
44 |
0.0003 |
| 791 |
ELECTROCARDIOGRAM QT PROLONGED |
10 |
0.0003 |
| 792 |
ABNORMAL BEHAVIOUR |
11 |
0.0003 |
| 793 |
ABDOMINAL PAIN LOWER |
7 |
0.0003 |
| 794 |
AMNESIA |
18 |
0.0003 |
| 795 |
CARDIOVASCULAR DISORDER |
7 |
0.0003 |
| 796 |
ABDOMINAL PAIN |
64 |
0.0003 |
| 797 |
INTERVERTEBRAL DISC PROTRUSION |
6 |
0.0003 |
| 798 |
OSTEONECROSIS |
9 |
0.0003 |
| 799 |
ACCIDENTAL OVERDOSE |
10 |
0.0003 |
| 800 |
HAEMATOMA |
7 |
0.0003 |
| 801 |
SKIN DISORDER |
9 |
0.0003 |
| 802 |
HEPATIC STEATOSIS |
5 |
0.0003 |
| 803 |
THINKING ABNORMAL |
5 |
0.0003 |
| 804 |
RASH PAPULAR |
6 |
0.0003 |
| 805 |
GAIT DISTURBANCE |
51 |
0.0003 |
| 806 |
GASTRITIS |
7 |
0.0003 |
| 807 |
HYPOAESTHESIA ORAL |
4 |
0.0003 |
| 808 |
DEVICE USE ERROR |
9 |
0.0003 |
| 809 |
LOSS OF CONSCIOUSNESS |
33 |
0.0003 |
| 810 |
HALLUCINATION, AUDITORY |
4 |
0.0003 |
| 811 |
ABSCESS |
4 |
0.0003 |
| 812 |
MUSCULOSKELETAL PAIN |
13 |
0.0002 |
| 813 |
BLOOD POTASSIUM INCREASED |
4 |
0.0002 |
| 814 |
PAIN IN EXTREMITY |
72 |
0.0002 |
| 815 |
HYPERSOMNIA |
7 |
0.0002 |
| 816 |
CARDIAC ARREST |
20 |
0.0002 |
| 817 |
DYSSTASIA |
7 |
0.0002 |
| 818 |
GASTROINTESTINAL HAEMORRHAGE |
20 |
0.0002 |
| 819 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0002 |
| 820 |
PSYCHOTIC DISORDER |
7 |
0.0002 |
| 821 |
BACK PAIN |
55 |
0.0002 |
| 822 |
EATING DISORDER |
5 |
0.0002 |
| 823 |
EXPOSURE VIA SKIN CONTACT |
6 |
0.0002 |
| 824 |
BLISTER |
13 |
0.0002 |
| 825 |
DIPLOPIA |
6 |
0.0002 |
| 826 |
HYPERKALAEMIA |
8 |
0.0002 |
| 827 |
CONSTIPATION |
49 |
0.0002 |
| 828 |
DYSPHAGIA |
21 |
0.0002 |
| 829 |
HYPOTHYROIDISM |
7 |
0.0002 |
| 830 |
TINNITUS |
10 |
0.0002 |
| 831 |
DIVERTICULITIS |
6 |
0.0002 |
| 832 |
FLUID RETENTION |
11 |
0.0002 |
| 833 |
BLOOD SODIUM DECREASED |
4 |
0.0002 |
| 834 |
MALAISE |
93 |
0.0002 |
| 835 |
FRACTURE |
4 |
0.0002 |
| 836 |
ARRHYTHMIA |
10 |
0.0002 |
| 837 |
DECREASED APPETITE |
49 |
0.0002 |
| 838 |
INTERNATIONAL NORMALISED RATIO INCREASED |
6 |
0.0002 |
| 839 |
DEVICE DISLOCATION |
9 |
0.0002 |
| 840 |
FLUSHING |
21 |
0.0002 |
| 841 |
APATHY |
3 |
0.0002 |
| 842 |
SINUSITIS |
21 |
0.0002 |
| 843 |
DRUG EFFECT DECREASED |
11 |
0.0002 |
| 844 |
ACUTE MYOCARDIAL INFARCTION |
6 |
0.0002 |
| 845 |
NAUSEA |
161 |
0.0002 |
| 846 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
4 |
0.0002 |
| 847 |
BLOOD GLUCOSE INCREASED |
38 |
0.0002 |
| 848 |
BLOOD PRESSURE ABNORMAL |
4 |
0.0002 |
| 849 |
DEVICE ISSUE |
18 |
0.0002 |
| 850 |
RESPIRATORY DISORDER |
6 |
0.0002 |
| 851 |
AGGRESSION |
10 |
0.0002 |
| 852 |
IRRITABILITY |
12 |
0.0002 |
| 853 |
DYSKINESIA |
8 |
0.0002 |
| 854 |
EYE PAIN |
11 |
0.0002 |
| 855 |
ANAPHYLACTIC SHOCK |
5 |
0.0002 |
| 856 |
URINARY TRACT INFECTION |
33 |
0.0002 |
| 857 |
FATIGUE |
150 |
0.0002 |
| 858 |
CRYING |
7 |
0.0002 |
| 859 |
ARTHRALGIA |
79 |
0.0002 |
| 860 |
MOUTH ULCERATION |
4 |
0.0002 |
| 861 |
CEREBROVASCULAR ACCIDENT |
32 |
0.0002 |
| 862 |
DEHYDRATION |
25 |
0.0002 |
| 863 |
DRY SKIN |
25 |
0.0002 |
| 864 |
NIGHT SWEATS |
6 |
0.0002 |
| 865 |
INCORRECT DOSE ADMINISTERED |
42 |
0.0002 |
| 866 |
PRODUCT DISPENSING ERROR |
4 |
0.0002 |
| 867 |
EYE DISORDER |
6 |
0.0002 |
| 868 |
RESPIRATORY ARREST |
5 |
0.0002 |
| 869 |
MOBILITY DECREASED |
13 |
0.0002 |
| 870 |
GAIT INABILITY |
6 |
0.0002 |
| 871 |
PLASMA CELL MYELOMA |
7 |
0.0002 |
| 872 |
UNDERDOSE |
13 |
0.0002 |
| 873 |
PAIN IN JAW |
5 |
0.0002 |
| 874 |
PRODUCT AVAILABILITY ISSUE |
4 |
0.0002 |
| 875 |
OEDEMA PERIPHERAL |
21 |
0.0002 |
| 876 |
ECZEMA |
9 |
0.0002 |
| 877 |
BLINDNESS |
7 |
0.0002 |
| 878 |
NEEDLE ISSUE |
5 |
0.0002 |
| 879 |
DIARRHOEA |
110 |
0.0002 |
| 880 |
DYSPNOEA |
94 |
0.0002 |
| 881 |
SKIN EXFOLIATION |
14 |
0.0002 |
| 882 |
LOCALISED INFECTION |
4 |
0.0002 |
| 883 |
BLOOD PRESSURE INCREASED |
25 |
0.0002 |
| 884 |
PRODUCT DOSE OMISSION ISSUE |
48 |
0.0002 |
| 885 |
DYSURIA |
6 |
0.0002 |
| 886 |
DRUG ADMINISTRATION ERROR |
5 |
0.0002 |
| 887 |
ABASIA |
4 |
0.0002 |
| 888 |
PRODUCT USE IN UNAPPROVED INDICATION |
40 |
0.0002 |
| 889 |
DRY MOUTH |
13 |
0.0002 |
| 890 |
CHEST PAIN |
29 |
0.0002 |
| 891 |
HYPERHIDROSIS |
20 |
0.0002 |
| 892 |
VISUAL ACUITY REDUCED |
5 |
0.0002 |
| 893 |
RENAL DISORDER |
7 |
0.0002 |
| 894 |
CONDITION AGGRAVATED |
45 |
0.0001 |
| 895 |
ANGER |
5 |
0.0001 |
| 896 |
PRODUCTIVE COUGH |
7 |
0.0001 |
| 897 |
COUGH |
41 |
0.0001 |
| 898 |
VISUAL IMPAIRMENT |
18 |
0.0001 |
| 899 |
HYPOGLYCAEMIA |
7 |
0.0001 |
| 900 |
DIABETES MELLITUS |
11 |
0.0001 |
| 901 |
PROCEDURAL PAIN |
4 |
0.0001 |
| 902 |
MEDICATION ERROR |
8 |
0.0001 |
| 903 |
HAEMOPTYSIS |
4 |
0.0001 |
| 904 |
PERIPHERAL SWELLING |
22 |
0.0001 |
| 905 |
HEART RATE DECREASED |
5 |
0.0001 |
| 906 |
PRODUCT DOSE OMISSION IN ERROR |
4 |
0.0001 |
| 907 |
HYPOACUSIS |
6 |
0.0001 |
| 908 |
DRUG INTERACTION |
22 |
0.0001 |
| 909 |
PRODUCT USE ISSUE |
26 |
0.0001 |
| 910 |
SWELLING FACE |
9 |
0.0001 |
| 911 |
THERAPY CESSATION |
7 |
0.0001 |
| 912 |
DIZZINESS |
68 |
0.0001 |
| 913 |
WEIGHT DECREASED |
38 |
0.0001 |
| 914 |
INFLUENZA |
15 |
0.0001 |
| 915 |
HOT FLUSH |
10 |
0.0001 |
| 916 |
INTESTINAL OBSTRUCTION |
5 |
0.0001 |
| 917 |
DISCOMFORT |
8 |
0.0001 |
| 918 |
VISION BLURRED |
18 |
0.0001 |
| 919 |
LIMB DISCOMFORT |
4 |
0.0001 |
| 920 |
FEMUR FRACTURE |
4 |
0.0001 |
| 921 |
RASH PRURITIC |
7 |
0.0001 |
| 922 |
PAIN |
79 |
0.0001 |
| 923 |
CARDIAC DISORDER |
12 |
0.0001 |
| 924 |
HAEMATOCHEZIA |
7 |
0.0001 |
| 925 |
ANXIETY |
36 |
0.0001 |
| 926 |
CYSTITIS |
4 |
0.0001 |
| 927 |
METABOLIC ACIDOSIS |
4 |
0.0001 |
| 928 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
6 |
0.0001 |
| 929 |
HIP FRACTURE |
4 |
0.0001 |
| 930 |
EXTRA DOSE ADMINISTERED |
5 |
0.0001 |
| 931 |
MUSCLE SPASMS |
22 |
0.0001 |
| 932 |
CATARACT |
7 |
0.0001 |
| 933 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
21 |
0.0001 |
| 934 |
OVERDOSE |
25 |
0.0001 |
| 935 |
NERVOUSNESS |
6 |
0.0001 |
| 936 |
FALL |
38 |
0.0001 |
| 937 |
DEVICE MALFUNCTION |
8 |
0.0001 |
| 938 |
FEELING ABNORMAL |
27 |
0.0001 |
| 939 |
DISTURBANCE IN ATTENTION |
6 |
0.0001 |
| 940 |
TREATMENT NONCOMPLIANCE |
6 |
0.0001 |
| 941 |
INFLUENZA LIKE ILLNESS |
9 |
0.0001 |
| 942 |
SKIN DISCOLOURATION |
5 |
0.0001 |
| 943 |
EYE SWELLING |
4 |
0.0001 |
| 944 |
NECK PAIN |
6 |
0.0001 |
| 945 |
ABDOMINAL PAIN UPPER |
22 |
0.0001 |
| 946 |
ILLNESS |
11 |
0.0001 |
| 947 |
DYSPNOEA EXERTIONAL |
4 |
0.0001 |
| 948 |
OCULAR HYPERAEMIA |
5 |
0.0001 |
| 949 |
NEOPLASM MALIGNANT |
7 |
0.0001 |
| 950 |
VERTIGO |
6 |
0.0001 |
| 951 |
CHEST DISCOMFORT |
10 |
0.0001 |
| 952 |
INSOMNIA |
26 |
0.0001 |
| 953 |
ERYTHEMA |
20 |
0.0001 |
| 954 |
ABDOMINAL DISTENSION |
10 |
0.0001 |
| 955 |
DEPRESSED MOOD |
5 |
0.0001 |
| 956 |
CHRONIC KIDNEY DISEASE |
7 |
0.0001 |
| 957 |
INTENTIONAL PRODUCT MISUSE |
8 |
0.0001 |
| 958 |
COLITIS ULCERATIVE |
4 |
0.0001 |
| 959 |
ALOPECIA |
17 |
0.0001 |
| 960 |
HYPERSENSITIVITY |
16 |
0.0001 |
| 961 |
WHEEZING |
5 |
0.0001 |
| 962 |
MIGRAINE |
8 |
0.0001 |
| 963 |
WEIGHT INCREASED |
18 |
0.0001 |
| 964 |
RHINORRHOEA |
5 |
0.0001 |
| 965 |
PALPITATIONS |
9 |
0.0001 |
| 966 |
MYOCARDIAL INFARCTION |
13 |
0.0001 |
| 967 |
EMOTIONAL DISTRESS |
9 |
0.0001 |
| 968 |
CONTUSION |
7 |
0.0001 |
| 969 |
NASOPHARYNGITIS |
13 |
0.0001 |
| 970 |
PRURITUS |
27 |
0.0001 |
| 971 |
MUSCULOSKELETAL STIFFNESS |
6 |
0.0001 |
| 972 |
NASAL CONGESTION |
4 |
0.0001 |
| 973 |
ANGIOEDEMA |
3 |
0.0001 |
| 974 |
SWELLING |
6 |
0.0001 |
| 975 |
CARDIAC FAILURE CONGESTIVE |
5 |
0.0001 |
| 976 |
GASTROOESOPHAGEAL REFLUX DISEASE |
5 |
0.0001 |
| 977 |
INTENTIONAL PRODUCT USE ISSUE |
5 |
0.0001 |
| 978 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
4 |
0.0001 |
| 979 |
SUICIDAL IDEATION |
5 |
0.0001 |
| 980 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 981 |
ASTHMA |
6 |
0.0001 |
| 982 |
DEPRESSION |
12 |
0.0001 |
| 983 |
DYSPEPSIA |
5 |
0.0001 |
| 984 |
JOINT SWELLING |
6 |
0.0000 |
| 985 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 986 |
ABDOMINAL DISCOMFORT |
7 |
0.0000 |
| 987 |
ARTHRITIS |
3 |
0.0000 |
| 988 |
NO ADVERSE EVENT |
6 |
0.0000 |
| 989 |
PSORIASIS |
4 |
0.0000 |
| 990 |
URTICARIA |
5 |
0.0000 |
| 991 |
DRUG DOSE OMISSION |
4 |
0.0000 |